🇺🇸 FDA
Pipeline program

Rosuvastatin and Ezetimibe morning or evening administration

AMI9

Approved small_molecule completed

Quick answer

Rosuvastatin and Ezetimibe morning or evening administration for Hypercholesterolemia is a Approved program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).

Program details

Company
COLLEGIUM PHARMACEUTICAL, INC
Indication
Hypercholesterolemia
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials